HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance

HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance

Brief description of study

In this study, subjects diagnosed with liver cancer undergo the HepQuant SHUNT diagnostic assay as a means to determine liver function. The results of this assay will potentially inform radiation treatment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Hepatocellular carcinoma,Liver cancer,Childs-Pugh B
  • Age: Between 18 Years - 99 Years
  • Gender: All


Updated on 16 Oct 2020. Study ID: 843529

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center